3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1/2
1
Status
Recruiting
4
Active not recruiting
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Prostatic Neoplasms
2
Interventions
Specimen Handling
111
Magnetic Resonance Spectroscopy
88
Carboplatin
58
pembrolizumab
57
Biopsy
56
Cisplatin
51
Nivolumab
46
Paclitaxel
39
Radiotherapy
38
Cyclophosphamide
38
Gemcitabine
33
Dexamethasone
31
Radiation
30
Bevacizumab
30
atezolizumab
27
Pemetrexed
27
Etoposide
27
olaparib
24
Lenalidomide
24
Doxorubicin
23
X-Rays
22
Vincristine
22
Prednisone
22
Leucovorin
22
Immunoglobulin G
22
Docetaxel
22
Disulfides
22
venetoclax
21
durvalumab
21
Rituximab
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
AZD5305
×
30 days
×
Clear all
NCT05367440
2026-06-01
PETRANHA
AstraZeneca
Phase 1/2
Active not recruiting
174 enrolled
NCT06120491
2026-05-27
EvoPAR-PR01
AstraZeneca
Phase 3
Active not recruiting
1,889 enrolled